Observational studyPediatric nephrology (Berlin, Germany)2019

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Meredith P Schuh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.